Funded Awards – October 2017

Funded Awards
PI Agency Title
Leonard Bacharier NIH/UM1/University of Wisconsin – Madison ICAC III – CRITICAL
Leonard Bacharier NIH/UM1/University of Wisconsin – Madison ICAC III – MUPPITS 2
Allan Doctor ICTS/ STAR Application of Community Based Group Model Building to…
Sarah Garwood SLCH Foundation Jennings School-Based Health Clinic
Dorothy Grange NIH William Syndrome Clinic
Carmen Halabi NIH/K08 Vascular Extracellular Matrix in Arterial Development …
Jeffrey Magee American Society of Hematology The Role of Inherited MLL3 Single Nucleotide Variants …
Jose Pineda NIH/R21 Development and Evaluation of A Bedside Guideline Engi…
Katie Plax SAMHSA HIV Prevention Navigator
Philip Spinella NIH/R21/Yale University Prevention of Central Venous Catheter-associated Throm…
Phillip Tarr NIH/R01 Phylogenomic, Transcriptomic, Viromic, and Immunoprote…
Neil White NIH/U01/Case Western Epidemiology of Diabetes Interventions and Complicatio…
Xunjun Xiao National Pancreas Foundation Cel-Hyb Confer Suspectibility to CP Through Proteotoxi…
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …